ARC
LIVE

Serial Number

79390974

Owner

ARC Regulatory Limited

Attorney

Amy L. Wright

Filing Date

Aug 16, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ARC Trademark

Serial Number: 79390974 • Registration: 8090389

ARC is a trademark filed by ARC Regulatory Limited on August 16, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ARC Regulatory Limited (4 trademarks)

Unit 1a Concourse Building 1,

Entity Type: 99

Trademark Details

Filing Date

August 16, 2023

Registration Date

January 6, 2026

Published for Opposition

August 5, 2025

Goods & Services

Education services, namely, providing training courses, online and live classes, seminars, webinars, workshops and tutorials in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; providing of training in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; education services in the medical and life sciences industries; educational services in relation to regulatory compliance, issues, updates and developments; educational services in relation to data integrity, unique device identification and regulatory readiness; education and training in relation to compliance and legal aspects of the European union In vitro Diagnostic Regulation; education services relating to quality services in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; legal education services; publication of instructional literature, none of the foregoing in connection with the travel industry; publishing, reporting, and writing of texts, other than publicity texts, none of the foregoing in connection with the travel industry; arranging and conducting conferences, workshops, seminars, symposium, competitions, conventions and meetings in the medical and life sciences industries; writing, reporting and publication of non-downloadable guidelines, reports, data and case studies relating to the medical and life sciences industries; advisory and consultancy services relating to all abovementioned services; none of the aforesaid relating to betting or gambling services; none of the aforesaid relating to AI technology specifically used in relation to player protection technology or risk reduction technology in the betting and gambling sector.

Computers, computer hardware and computer peripheral devices; computer software, computer application software, application software for mobile devices, all of the aforesaid being downloadable or recorded and for the purpose of accessing, navigating, analysing, updating and identifying regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; Computer software, computer application software, application software for mobile devices, all of the aforesaid being downloadable or recorded and for the purpose of delivering training and educational content in respect of regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; downloadable and recorded computer software for generating reports concerning regulatory requirements in the medical and life sciences industries; downloadable and recorded computer software for delivering training in relation to regulatory requirements in the medical and life sciences industries; downloadable publications, namely, magazines, newsletters, periodicals and brochures, all in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; downloadable and recorded media including written, image, video, audio and visual content, and infographics, namely e-books, CDs, DVDs, audio and video recordings, digital image files, podcasts and webinars in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; downloadable toolkits containing education, teaching and training resources comprised of downloadable guidelines, reports and data relating to regulatory compliance in the medical and life sciences industries; downloadable guidelines, reports and data relating to regulatory compliance in the medical and life sciences industries; none of the aforesaid relating to betting or gambling services; none of the aforesaid relating to AI technology specifically used in relation to player protection technology or risk reduction technology in the betting and gambling sector; none of the aforesaid in relation to the manufacture, provision, or supply of microprocessors, motherboard chipsets, network interface controllers and integrated circuits, flash memory, graphics chips, embedded processors nor other devices or software related to electronic design automation solutions and services

Clinical medical consultation services; medical information; professional consultancy relating to health care; advisory services relating to medical and surgical instruments and devices; consulting and advisory services relating to obtaining and maintaining commerical product certifications for medical and surgical instruments and devices; consultancy and information services relating to medical, pharmaceutical and biopharmaceutical products; consulting and advisory services relating to the European Union in vitro diagnostic regulation (IVDR); consulting and advisory services relating to the European Union medical device regulation (MDR); consulting and advisory services relating to medical aspects of the European Union in vitro diagnostic regulation (IVDR); consulting and advisory services relating to medical aspects of the European Union medical device regulation (MDR); preparation of reports relating to medical matters; preparation of clinical and performance evaluation reports; preparation of clinical and performance evaluation reports for medical devices; information, consultancy and advisory services relating to all above mentioned services.

Business organization and administration, none of the foregoing in connection with the travel industry; providing office functions, none of the foregoing in connection with the travel industry; collection, compilation, analysis, reporting and dissemination of statistics, data and information, none of the foregoing in connection with the travel industry; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing applications for regulatory approval of medical devices, medical technologies, medications, pharmaceuticals, and biotechnology; providing information online regarding preparing and filing applications for regulatory submission management; business and advisory consultancy services relating to obtaining and maintaining commercial product certifications

Scientific, technological and industrial analysis, research and design services in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; conducting and designing clinical trials for others; laboratory testing of materials; consultancy services related to laboratory testing of materials; clinical research in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; biological research and medical research; site monitoring services; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical product evaluation; product quality evaluation; quality control services for others; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the medical and life sciences industries; scientific research, analysis, testing, and related scientific studies in the medical and life sciences industries; consulting services in the medical and life sciences industries; biotechnology, biotechnology research consulting services; pharmaceutical research and product development for use in manufacturing; consulting services for others in the field of designing pre-clinical and clinical studies and trials for others; technical writing; technical writing for others; testing, analysis and evaluation of the services of others for the purpose of certification; testing of apparatus in the field of medical devices for certification purposes; electronic data storage; software as a service [SaaS] for the purpose of accessing, navigating, analysing, updating and identifying regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; software as a service [SaaS] for the purpose of delivering training, educational content and reports in respect of regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; providing online, non-downloadable software for the purpose of accessing, navigating, analysing, updating and identifying regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; providing online, non-downloadable software for the purpose of delivering training, educational content and reports in respect of regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; software design, development and engineering, none of the foregoing in connection with the travel industry; computer software consultancy, none of the foregoing in connection with the travel industry; providing online, nondownloadable software for generating reports concerning regulatory requirements in the medical and life sciences industries; providing online, non-downloadable software for delivering training in relation to regulatory requirements in the medical and life sciences industries; information, consultancy and advisory services relating to all abovementioned services; none of the aforesaid relating to betting or gambling services; none of the aforesaid relating to AI technology specifically used in relation to player protection technology or risk reduction technology in the betting and gambling sector; none of the foresaid in relation to the manufacture, provision, or supply of microprocessors, motherboard chipsets, network interface controllers and integrated circuits, flash memory, graphics chips, embedded processors nor other devices or software related to electronic design automation solutions and services.

Legal services; regulatory and legal compliance auditing; advisory services relating to regulatory affairs; expert consultancy relating to legal issues regulatory compliance consulting services in the life sciences fields; regulatory compliance consulting services in the life sciences fields namely, reviewing standards and practices to assist others with compliance with governmental laws, regulations and rules pertaining to medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; consulting and advisory services relating to legal aspects of the European Union in vitro diagnostic regulation (IVDR); consulting and advisory services relating to legal aspects of the European Union medical device regulation (MDR); legal support services; information, consultancy and advisory services relating to all above mentioned services.

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 6, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 6, 2026 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Dec 17, 2025 CHPB
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 14, 2025 ETOP
ASSIGNED TO PETITION STAFF
Dec 11, 2025 APET
NEW REPRESENTATIVE AT IB RECEIVED
Nov 29, 2025 NREP
ASSIGNED TO EXAMINER
Nov 6, 2025 DOCK
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 24, 2025 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 26, 2025 ETOF
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 22, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 6, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 6, 2025 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2025 TROA
NON-FINAL ACTION WRITTEN
Dec 10, 2024 CNRT
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Dec 6, 2024 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Nov 29, 2024 LIMG
EXAMINER'S AMENDMENT ENTERED
Nov 15, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 15, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 15, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 15, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 29, 2024 TROA
REFUSAL PROCESSED BY IB
Jun 23, 2024 RFNT
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 14, 2024 ADCH
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 23, 2024 RFCS
REFUSAL PROCESSED BY MPU
May 23, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 11, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 10, 2024 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
May 10, 2024 RFWR
APPLICATION FILING RECEIPT MAILED
Apr 24, 2024 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 19, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 18, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 17, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 12, 2024 NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 7, 2024 REPR